# Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation

> **NCT02847546** · — · COMPLETED · sponsor: **C. R. Bard** · enrollment: 25 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** True™ Flow Valvuloplasty Perfusion Catheter

## Key facts

- **NCT ID:** NCT02847546
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847546, "Evaluation of the BARD® True™ Flow Valvuloplasty Perfusion Catheter for Aortic Valve Dilatation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02847546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*